North America Poultry Diagnostic Market Forecast to 2030

North America Poultry Diagnostic Market Forecast to 2030 – Regional Analysis – By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests and Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others] and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)

Send Enquiry

$2,485$3,885

Description

The North America poultry diagnostic market is expected to grow from US$ 118.89 million in 2022 to US$ 253.67 million by 2030. It is estimated to grow at a CAGR of 9.9% from 2022 to 2030.

Farm-Side Diagnostic Poultry Platform Fuel North America Poultry Diagnostic Market

Nowadays, a simple farm-side molecular diagnostic platform and complementary surveillance software are installed at the farm site with a high infection rate to curb the spread of disease by test poultry animals for viral and bacterial pathogens. Also, within a short span the poultry industry team can successfully develop a portable, battery-powered, stand-alone diagnostic platform abiding by World Health Organization (WHO) guidelines to ensure that these devices can be operated anywhere on the farm, eliminating the need for laboratory structure, trained personnel, and additional equipment. Also, the cost of the device is 95% lower than comparable commercially available devices and validated against gold standard devices showing equivalent standards. Therefore, implementation of such farm-side poultry disease diagnostic platforms would help farmers keep a check on the spread of infectious disease, antimicrobial resistance (AMR), and zoonotic pathogens by enabling early detection and containment.

North America Poultry Diagnostic Market Overview

The North America poultry diagnostics market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period due to the increasing consumption of poultry-derived products and growing consumer awareness regarding food safety. Moreover, as per the statistics published by the United Nations Food and Agriculture Organization (UNFAO), in 2022, there was an increase in the production of eggs and hens in North America.

North America Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)

North America poultry diagnostic market Segmentation

The North America poultry diagnostic market is segmented into test type, disease, and country.

Based on test type, the North America poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (hi), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the North America poultry diagnostic market in 2022.

Based on disease, the North America poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian influenza segment held the largest share of the North America poultry diagnostic market in 2022.

Based on country, the North America poultry diagnostic market is segmented into the US, Canada, and Mexico. The US dominated the North America poultry diagnostic market in 2022.

Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and Bioneer Corp are some of the leading companies operating in the North America poultry diagnostic market.

Summary Info

Industry:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 9.9% CAGR, the North America Poultry Diagnostic Market is Speculated to be Worth US$ 253.67 Million by 2030, says the research team

According to the research team’ research, the North America poultry diagnostic market was valued at US$ 118.89 million in 2022 and is expected to reach US$ 253.67 million by 2030, registering a CAGR of 9.9% from 2022 to 2030. Rising zoonotic disease cases and technological advancements attributed to the North America poultry diagnostic market expansion.

Zoonotic diseases are caused by harmful viruses, bacteria, parasites, and fungi. These germs cause different illnesses, ranging from mild to severe, in humans and animals, which may even lead to fatalities. According to the World Health Organization (WHO) 2023 report, ~60% of the emerging infectious diseases reported globally are zoonoses. Additionally, in the last two decades, the emergence of various zoonotic diseases has been reported in 18 out of 22 countries, resulting in explosive outbreaks and high fatalities. Advancements in biotechnology and molecular epidemiology have made it easier to develop vaccines and therapeutics, and diagnostics processes (tools, equipment, consumables, etc.) to identify and track the transmission of zoonoses. iVetNet is an information platform run and maintained by the International Atomic Energy Agency (IAEA) in cooperation with the Food and Agriculture Organization of the United Nations (FAO) to compile, disseminate, and harmonize techniques for the detection and characterization of transboundary animal and zoonotic pathogens. Launched in 2022, iVetNet can bring together over 1,000 laboratories and offering users access to the information, validation, and verified procedures for the detection and characterization of animal and skin disease, Ebola, Zika, and COVID-19.

On the contrary, insufficient welfare measures for poultry hamper the North America poultry diagnostic market.

Based on test type, the North America poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held 45.5% share of North America poultry diagnostic market in 2022, amassing US$ 54.09 million. It is projected to garner US$ 120.00 million by 2030 to expand at 10.5% CAGR during 2022–2030.

In terms of disease, the North America poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian influenza segment held 29.5% share of North America poultry diagnostic market in 2022, amassing US$ 35.13 million. It is projected to garner US$ 76.54 million by 2030 to expand at 10.2% CAGR during 2022–2030.

By country, the North America poultry diagnostic market has been categorized into the US, Canada, and Mexico. Our regional analysis states that US captured 86.9% share of North America poultry diagnostic market in 2022. It was assessed at US$ 103.29 million in 2022 and is likely to hit US$ 224.65 million by 2030, exhibiting a CAGR of 10.2% during 2022–2030.

Key players operating the North America poultry diagnostic market are Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and Bioneer Corp, among others.

In Jul-2022: A leading research-driven biopharmaceutical company, the life science company Evotec SE and bioMérieux, a world leader in in vitro diagnostics, announced partnership to create the next-generation of antimicrobials along with actionable diagnostics to fight Antimicrobial Resistance (AMR). In Mar-2020: BioChek, the specialist company to offer innovative and user-friendly veterinary diagnostic tools, today announced the successful acquisition of BIOTECON. The merger creates a new diagnostic testing targeting mainly the markets related to meat, egg, dairy, baby food, and others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America poultry diagnostic market.
o Highlights key in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in North America poultry diagnostic market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Poultry Diagnostics Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Zoonotic Disease Cases
4.1.2 Technological Advancements
4.2 Market Restraint
4.2.1 Insufficient Welfare Measures for Poultry
4.3 Market Opportunity
4.3.1 Government Support and Initiatives
4.4 Market Trends
4.4.1 Farm-Side Diagnostic Poultry Platform
4.5 Impact Analysis
5. North America Poultry Diagnostics Market – Market Analysis
5.1 North America Poultry Diagnostics Market Revenue (US$ Thousand), 2022 – 2030
6. North America Poultry Diagnostics Market – Revenue and Forecast to 2030 – by Test Type
6.1 Overview
6.2 North America Poultry Diagnostics Market Revenue Share, by Test Type 2022 & 2030 (%)
6.3 Enzyme-Linked Immunosorbent Assay (ELISA) Tests
6.3.1 Overview
6.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Tests: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
6.4 Polymerase Chain Reaction (PCR) Tests
6.4.1 Overview
6.4.2 Polymerase Chain Reaction (PCR) Tests: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
6.5 Hemagglutination-Inhibition (HI)
6.5.1 Overview
6.5.2 Hemagglutination-Inhibition (HI): North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
6.6 Others
6.6.1 Overview
6.6.2 Others: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
7. North America Poultry Diagnostics Market – Revenue and Forecast to 2030 – by Disease
7.1 Overview
7.2 North America Poultry Diagnostics Market Revenue Share, by Disease 2022 & 2030 (%)
7.3 Avian Influenza
7.3.1 Overview
7.3.2 Avian Influenza: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
7.4 Infectious Bronchitis
7.4.1 Overview
7.4.2 Infectious Bronchitis: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
7.5 Avian Salmonellosis
7.5.1 Overview
7.5.2 Avian Salmonellosis: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
7.6 Newcastle Disease
7.6.1 Overview
7.6.2 Newcastle Disease: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
7.7 Avian Mycoplasmosis
7.7.1 Overview
7.7.2 Avian Mycoplasmosis: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
7.8 Others
7.8.1 Overview
7.8.2 Others: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
8. North America Poultry Diagnostics Market – Revenue and Forecast to 2030 – Country Analysis
8.1 North America Poultry Diagnostics Market
8.1.1 Overview
8.1.2 North America Poultry Diagnostics Market, by Country, 2022 & 2030 (%)
8.1.2.1 US Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
8.1.2.1.1 Overview
8.1.2.1.2 US Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
8.1.2.1.3 US Poultry Diagnostics Market, by Test Type, 2020-2030 (US$ Thousand)
8.1.2.1.4 US Poultry Diagnostics Market, by Disease, 2020-2030 (US$ Thousand)
8.1.2.2 Canada Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
8.1.2.2.1 Overview
8.1.2.2.2 Canada Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
8.1.2.2.3 Canada Poultry Diagnostics Market, by Test Type, 2020-2030 (US$ Thousand)
8.1.2.2.4 Canada Poultry Diagnostics Market, by Disease, 2020-2030 (US$ Thousand)
8.1.2.3 Mexico Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
8.1.2.3.1 Overview
8.1.2.3.2 Mexico Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
8.1.2.3.3 Mexico Poultry Diagnostics Market, by Test Type, 2020-2030 (US$ Thousand)
8.1.2.3.4 Mexico Poultry Diagnostics Market, by Disease, 2020-2030 (US$ Thousand)
9. North America Poultry Diagnostics Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the North America Poultry Diagnostics Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Thermo Fisher Scientific Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Idexx Laboratories Inc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Qiagen NV
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Eurofins Scientific SE
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Boehringer Ingelheim International GmbH
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Zoetis Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 BioCheck BV
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Bioneer Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
11. Appendix
11.1 About Us
11.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Poultry Diagnostics Market Segmentation
Table 2. US Diagnostics Market, by Test Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 3. US Diagnostics Market, by Disease – Revenue and Forecast to 2030 (US$ Thousand)
Table 4. Canada Poultry Diagnostics Market, by Test Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 5. Canada Poultry Diagnostics Market, by Disease – Revenue and Forecast to 2030 (US$ Thousand)
Table 6. Mexico Poultry Diagnostics Market, by Test Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 7. Mexico Poultry Diagnostics Market, by Disease – Revenue and Forecast to 2030 (US$ Thousand)
Table 8. Recent Inorganic Growth Strategies in the North America Poultry Diagnostics Market
Table 9. Recent Organic Growth Strategies in the North America Poultry Diagnostics Market
Table 10. Glossary of Terms, North America Poultry Diagnostics Market

LIST OF FIGURES

Figure 1. North America Poultry Diagnostics Market Segmentation, By Country
Figure 2. North America Poultry Diagnostics Market: Key Industry Dynamics
Figure 3. North America Poultry Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Poultry Diagnostics Market Revenue (US$ Thousand), 2020 – 2030
Figure 5. North America Poultry Diagnostics Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 6. Enzyme-Linked Immunosorbent Assay (ELISA) Tests: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 7. Polymerase Chain Reaction (PCR) Tests: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 8. Hemagglutination-Inhibition (HI): North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 9. Others: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. North America Poultry Diagnostics Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 11. Avian Influenza: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 12. Infectious Bronchitis: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Avian Salmonellosis: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 14. Newcastle Disease: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. Avian Influenza: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 16. Others: North America Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 17. North America Poultry Diagnostics Market, by Key Country – Revenue (2022) (US$ Thousand)
Figure 18. North America Poultry Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 19. US Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 20. Canada Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Mexico Poultry Diagnostics Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 22. Growth Strategies in the North America Poultry Diagnostics Market

The List of Companies – North America Poultry Diagnostic Market

o Thermo Fisher Scientific Inc
o Idexx Laboratories Inc
o Qiagen NV
o Eurofins Scientific SE
o Boehringer Ingelheim International GmbH
o Zoetis Inc
o BioCheck BV
o Bioneer Corp

Reviews

There are no reviews yet.

Be the first to review “North America Poultry Diagnostic Market Forecast to 2030”